GYRE Latest Press Releases

-- January 5, 2026 --

Gyre Therapeutics Announces Alignment with China's CDE on Conditional Approval Pathway and Priority Review Eligibility for Hydronidone Following Pre-NDA Meeting Globe Newswire 7:00 AM

-- November 7, 2025 --

Gyre Therapeutics Reports Third Quarter 2025 and Year-to-Date Financial Results and Provides Business Update Globe Newswire 6:00 AM

-- October 15, 2025 --

Gyre Therapeutics Announces Completion of Patient Enrollment in Phase 3 Clinical Trial of Pirfenidone Capsules for the Treatment of Pneumoconiosis Globe Newswire 7:00 AM

-- October 14, 2025 --

Gyre Therapeutics to Present Results from Positive Phase 3 Clinical Trial Evaluating Hydronidone for the Treatment of Liver Fibrosis in Chronic Hepatitis B at AASLD-The Liver Meeting 2025 Globe Newswire 7:00 AM

-- September 5, 2025 --

Gyre Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference Globe Newswire 4:05 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software